Zobrazení zdroje stránky Godfreykonradsen8960

The experimental sealers have potential to overcome sealing ability issues of sealers.BioUnion filler incorporated into restorative/coating materials is a new bio-functional glass powder. The most unique function of BioUnion filler is its ability to release Zn2+ in acidic environments. In this study, the ion release profile of BioUnion filler under acidic conditions and its antibacterial effects against Streptococcus mutans were evaluated. The concentrations of Zn2+ released from BioUnion fillers into acetic acids were greater than those released into water. S. mutans inhibition by BioUnion fillers was greater with sucrose than without sucrose, reflecting a decrease in suspension pH in response to the addition of sucrose. Exposure to acids increased Zn2+ release from BioUnion fillers, and the fillers after repeated exposure to acids demonstrated inhibitory effects against S. mutans. These findings suggest that BioUnion filler accelerated the release of Zn2+ under acidic conditions, which induced bactericidal/inhibitory effects against S. mutans.To study the effect of central retainer shape and abduction angle during tooth preparation on stress distribution in endocrown-restored molars via finite element (FE) analysis, we constructed five FE models with different central retainer shapes and abduction angles. Under an oblique load, the distributions of maximum tensile stress in cervical dentin around the endocrown and on the cement layer, as well as maximum shear stress on the cement layer, were more balanced in the FE model in which the central retainer shape was generated based on the anatomical form of the pulp chamber. Moreover, there were no differences in stress distributions among FE models with different abduction angles. Therefore, the shape of the central retainer should be designed on the basis of the anatomical form of the pulp chamber; abduction angle during tooth preparation does not influence the repair effect of endocrown-restored mandibular molars.This study assessed the impact of surface treatments and repair resin reinforcement with zirconium oxide nano-particles (nano-ZrO2) on flexural strength (FS) of repaired denture base. A total of 320 heat-polymerized acrylic resin specimens were prepared and sectioned creating 2-mm gap. According to repair surface treatment, specimens were distributed into four groups I) methyl methacrylate (M); II) alumina-blasted (AB); III) AB+silane coupling agent (SC); and IV) AB+methacrylate based composite bonding agent (MA). Groups were subdivided into 4 (n=20) according to nano-ZrO2 concentration (0, 2.5, 5, 7.5 wt%). Half the specimens were thermo-cycled before testing. [https://www.selleckchem.com/products/nvs-stg2.html NVS-STG2] FS was determined by three-point bending test. Statistical analysis was done using ANOVA and Tukey-Kramer multiple comparison tests, with α=0.05. Alumina-blasting+(SC) or (MA) significantly increased FS of repaired specimens compared to control (p less then 0.05). All surface-treated specimens combined with nano-ZrO2 reinforced repair resin significantly increased FS.BACKGROUND In non-diabetic patients with acute coronary syndrome, stress hyperglycemia occasionally occurs and is related to their mortality. Whether transient elevation of glucose affects arrhythmia susceptibility in non-diabetic hearts with non-uniform contraction was examined.Methods and ResultsForce, intracellular Ca2+([Ca2+]i), and membrane potential were measured in trabeculae from rat hearts. Non-uniform contraction was produced by a jet of paralyzing solution. Ca2+waves and arrhythmias were induced by electrical stimulation (2.0 mmol/L [Ca2+]o). The activity of Ca2+/calmodulin-dependent protein kinaseII (CaMKII) was measured. An elevation of glucose from 150 to 400 mg/dL increased the velocity of Ca2+waves and the number of spontaneous action potentials triggered by electrical stimulation. Besides, the elevation of glucose increased the CaMKII activity. In the presence of 1 μmol/L KN-93, the elevation of glucose did not increase the velocity of Ca2+waves and the number of triggered action potentials. In addition, in the presence of 1 μmol/L autocamtide-2 related inhibitory peptide or 50 μmol/L diazo-5-oxonorleucine, the elevation of glucose did not increase the number of triggered action potentials. Furthermore, the elevation of glucose by adding L-glucose did not increase their number. CONCLUSIONS In non-diabetic hearts with non-uniform contraction, transient elevation of glucose increases the velocity of Ca2+waves by activating CaMKII,probably through glycosylation with O-linked β-N-acetylglucosamine, thereby increasing arrhythmia susceptibility.BACKGROUND The aim of this study was to evaluate the efficacy and safety of transdermal β-blocker patches, which offer stable blood concentration and easy availability during operation, for prevention of perioperative myocardial injury (PMI) in high-risk patients.Methods and ResultsIn this randomized controlled trial, patients aged &gt;60 years with hypertension and high revised cardiac risk index (≥2) undergoing non-cardiac surgery were randomly assigned to a bisoprolol patch or control group. Primary efficacy outcome was incidence of PMI, defined as postoperative high-sensitivity cardiac troponin T (hs-cTnT) &gt;0.014ng/mL and relative hs-cTnT change ≥20%. Secondary efficacy outcomes were number of cardiovascular events and 30-day mortality. From November 2014 to February 2019, 240 patients from 5 hospitals were enrolled in this study. The incidence of PMI was 35.7% in the bisoprolol patch group and 44.5% in the control group (P=0.18). Incidence of major adverse cardiac events including non-critical myocardial infarction, strokes, decompensated heart failure and tachyarrhythmia was similar between the 2 groups. Tachyarrhythmia tended to be higher in the control group. There were no significant differences in safety outcomes including significant hypotension and bradycardia requiring any treatment between the 2 groups. CONCLUSIONS Bisoprolol patches do not influence the incidence of PMI and cardiovascular events in high-risk patients undergoing non-cardiac surgery, but perioperative use of these patches is safe.